SCHEMBL11574253

SCHEMBL11574253

Oc1ccccc1CNCC(O)CNCc1ccccc1O

nearest known ligand 0.69

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.69
CYP2D6 P10635 1/20 0.69
HIF1A Q16665 1/20 0.69
CA12 O43570 6/20 0.64
CA2 P00918 6/20 0.64
CA9 Q16790 5/20 0.60
KDM4E B2RXH2 1/20 0.60
HSD17B10 Q99714 1/20 0.60
MPO P05164 6/20 0.58
PKM P14618 1/20 0.56
SLC6A4 P31645 1/20 0.55
MAPT P10636 2/20 0.49
ALDH1A1 P00352 2/20 0.47
MEN1 O00255 1/20 0.47
HTT P42858 1/20 0.47
KMT2A Q03164 1/20 0.47
HPGD P15428 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28232345 0.91 TSHR (0.62) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL27537010 0.88 TSHR (0.69) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL11977377 0.86 TSHR (0.67) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL460754 0.83 TSHR (1.00) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL18756245 0.82 TSHR (0.67) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL14580319 0.82 TSHR (0.67) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL13995849 0.79 TSHR (0.62) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL13995732 0.79 TSHR (0.62) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL12996041 0.79 TSHR (0.62) TSHRCYP2D6HIF1ACA12CA2
SCHEMBL11130325 0.79 TSHR (0.56) TSHRCYP2D6HIF1ACA12CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7238339-B2 Bifunctional chelating compounds containing hydroxamic acid residues DRAXIS SPECIALTY PHARMACEUTICALS INC. (CA) 2007-07-03 US disclosed
US-7238339-B2 Bifunctional chelating compounds containing hydroxamic acid residues DRAXIS SPECIALTY PHARMACEUTICALS INC. (CA) 2007-07-03 US disclosed
US-4116991-A HYDROXY-CONTAINING AGENTS FOR CHELATING METAL IONS AND A PROCESS FOR PREPARING SAME MANUFACTURE DE PRODUITS CHIMIQUES PROTEX (FR) 1978-09-26 US disclosed